ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Jasper Commerce Inc

Jasper Commerce Inc (JPIM.WT)

0.005
0.00
(0.00%)
Closed 26 January 8:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

JPIM.WT News

Official News Only
0 articles were found

Discussion

View Full Feed
maddyandboomer maddyandboomer 26 seconds ago
Need a good honest company first before getting what you call good investors....and axxa ain't it....they have shown their colors and resembles red flags...not green $ signs
AXXA
Fire_starter Fire_starter 46 seconds ago
🔥🔥🔥500 BILLION FOR THE CURE TO CANCER M-RNA VACCINE🔥🔥🔥
RNAZ
Smartypants2 Smartypants2 49 seconds ago
If jurisdiction was an issue, XTI's lawyers would have brought it as a reason for dismissal previously. Maybe they did -- and the judge already ruled against them. Either way, it's very doubtful it's still an issue in this case.
XERI
jsc52033 jsc52033 53 seconds ago
but you follow the penny stocks why
BMXI
IcyGalaxy60 IcyGalaxy60 2 minutes ago
What about 500k down payement for mt.Vernon?
NBRI
gitreal gitreal 2 minutes ago
I don't invest in scams.
BMXI
doc2016 doc2016 2 minutes ago
me:



the ban on outgoing messaging from federal agencies should surprise no one. the new administration won this cycle by emphasizing it was time for changes in defense to state to homeland security to treasury to healthcare.meta and data; meta data.
of course
NVDA
jour_trader jour_trader 3 minutes ago
I believe there is an authorized generic for OxyContin, but that's not quite the same. Once generics are approved the market price will tank, just like Vyvanse will. If Elite were the only one to get the approval that is one thing, but it is not the case. Buying Elite would not stop OxyContin pricin
ELTP
mmayr mmayr 3 minutes ago
Charlie Rich * Rollin' with the Flow 1977 HQ

[yt]b9_7ByKnwWY[/yt]

https://www.youtube.com/watch?v=b9_7ByKnwWY
StockItOut StockItOut 3 minutes ago
You're wrong. That's why you hide behind "probably."
XERI
north40000 north40000 3 minutes ago
Good idea, moms. We have both MNMD and PFE in our portfolios. PFE's expensive acquisition of SGEN(very profitable for us) has been slow to bring enough revenue to the balance sheet to solve PFE's problem being termed a laggard in pharma-land. HLS in Canada terminated a contract with PFE that involve
AMRN MNMD PFE
Ms Labonte Ms Labonte 4 minutes ago
Next leg up wide open $weet$$
WEET
getmoreshares getmoreshares 4 minutes ago
Good Afternoon-- catching up on the posts!
Smartypants2 Smartypants2 5 minutes ago
You don't even know the difference between "knew" and "new," I knew it!
XERI
Monksdream Monksdream 5 minutes ago
RAIL
https://investorshub.advfn.com/uimage/uploads/2025/1/25/zlxqsIMG_4814.gif
RAIL
misterfishman misterfishman 5 minutes ago
Be careful the bird like sitting on high voltage lines lol.
IGPK
Steady_T Steady_T 5 minutes ago
Selection issues for an OLE are many.

There are the drop outs from the original trial. That selects against those who can not tolerate the drug or the titration rate.
There are those that don't choose to go into the OLE for whatever reason. That is self selection.
There
AVXL
Smartypants2 Smartypants2 6 minutes ago
Once again, you are absolutely incorrect. But at least you are consistent.
XERI
MEPinvest MEPinvest 6 minutes ago
Do you interpret that as a good thing or a bad thing? Do you think they're being ominous and distressful to investors or cooking up something good for all?
CRTG
misterfishman misterfishman 6 minutes ago
I hope so. Sometime this year.
IGPK
jsc52033 jsc52033 7 minutes ago
are you actualy invest in BMXI or is this just boad you can talk on
BMXI
juicyjuice10002 juicyjuice10002 7 minutes ago
The financial advisor was advised by the insider to buy the shares but that conversation was kept secret. Insider advising the financial advisor is more likely.
FNMA
3331 3331 7 minutes ago
BIEL: VAGUS NERVE PATENT (PENDING)
NY Post - Jan. 23, 2025
Implantable vagus nerve stimulation (VNS) devices, which can cost $50,000, have long been used to treat epilepsy, depression and stroke. That’s because jolting the vagus nerve — the longest cranial nerve in the body — can help
Monksdream Monksdream 7 minutes ago
MESO
https://investorshub.advfn.com/uimage/uploads/2025/1/25/rkzrzIMG_4813.gif
MESO